LifeStance Health Group, Inc. (LFST) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 14.50M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 258.99M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 2.18B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $14.50M | $258.99M | (m) | (m) | $2.18B | (m) |
| 2026-03-31 | (m) | (m) | $18.13M | $262.46M | (m) | (m) | $2.15B | (m) |
| 2025-12-31 | (m) | (m) | $14.50M | $265.93M | (m) | (m) | $2.20B | (m) |
| 2025-09-30 | (m) | (m) | $12.69M | $269.39M | (m) | (m) | $2.15B | (m) |
| 2025-06-30 | (m) | (m) | $10.88M | $272.86M | (m) | (m) | $2.15B | (m) |
| 2025-03-31 | (m) | (m) | $9.06M | $276.32M | (m) | (m) | $2.10B | (m) |
| 2024-12-31 | (m) | (m) | $7.25M | $279.79M | (m) | (m) | $2.12B | (m) |
| 2024-09-30 | (m) | (m) | $2.92M | $279.06M | (m) | (m) | $2.11B | (m) |
| 2024-06-30 | (m) | (m) | $2.92M | $279.46M | (m) | (m) | $2.12B | (m) |
| 2024-03-31 | (m) | (m) | $2.92M | $279.87M | (m) | (m) | $2.11B | (m) |
| 2023-12-31 | (m) | (m) | $2.92M | $280.29M | (m) | (m) | $2.11B | (m) |
| 2023-09-30 | (m) | (m) | $2.60M | $248.37M | (m) | (m) | $2.18B | (m) |
| 2023-06-30 | (m) | (m) | $2.60M | $248.72M | (m) | (m) | $2.17B | (m) |
| 2023-03-31 | (m) | (m) | $2.35M | $224.76M | (m) | (m) | $2.16B | (m) |
| 2022-12-31 | (m) | (m) | $2.35M | $225.08M | (m) | (m) | $2.17B | (m) |
| 2022-09-30 | (m) | (m) | $2.15M | $212.04M | (m) | (m) | $1.98B | (m) |
| 2022-06-30 | (m) | (m) | $1.50M | $203.36M | (m) | (m) | $1.97B | (m) |
| 2022-03-31 | (m) | (m) | $1.32M | $177.38M | (m) | (m) | $1.96B | (m) |
| 2021-12-31 | (m) | (m) | $1.32M | $157.42M | (m) | (m) | $1.93B | (m) |
| 2021-09-30 | (m) | (m) | $1.32M | $157.45M | (m) | (m) | $1.91B | (m) |
| 2021-06-30 | (m) | (m) | $1.62M | $157.07M | (m) | (m) | $1.91B | (m) |
| 2020-12-31 | (m) | (m) | $3.74M | $362.53M | (m) | (m) | $1.57B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |